ZURICH 04 October 2022: Apricot Therapeutics AG signed an options agreement with the University of Zurich to evaluate patents rights for two patent applications based on research from the group of Lucas Pelkmans.
ZURICH 04 October 2022: Apricot Therapeutics AG signed an options agreement with the University of Zurich to evaluate patents rights for two patent applications based on research from the group of Lucas Pelkmans.